Posts tagged ‘lymphoma’


College student with lymphoma advises: Don’t let cancer define you

April 9, 2014 | by
Anna Kendrick with cancer patient at City of Hope
Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or career, and fertility. All of these challenges point to the need for more research to improve care and follow-up for this age group. Here, one of those patients –  20-year-old Monica Curiel – shares her experience with lymphoma and also her advice for others in her position. ** By Monica Curiel Lymphoma…

AACR 2014: Hormone therapy linked to lower non-Hodgkin lymphoma risk

April 7, 2014 | by
pills in blister pack
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma. City of Hope researchers found that menopausal hormone therapy use appears linked to a lower risk of B-cell non-Hodgkin lymphoma. Sophia Wang, Ph.D., associate professor at City of Hope’s Division of Cancer Etiology and…

Meet our doctors: Hematologist Leslie Popplewell on clinical trials

March 2, 2014 | by
Clinical trials
Research studies known as clinical trials have led to countless advances in the diagnosis, treatment and prevention of cancer. These studies test the effectiveness of new medical approaches that can lead to fewer treatment-related side effects and, in some cases, improved outcomes for patients with certain cancers. Leslie Popplewell says clinical trials can offer additional treatment options for patients. But many patients know little about clinical trials, much less what’s involved to participate. Here,  Leslie Popplewell, associate professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, explains how clinical trials work and…

Lymphoma changed Emmet and Toni Stephenson; now they want to change it

February 12, 2014 | by
Stephensons
During their 46-year marriage – an attraction begun as kindergarten sweethearts – entrepreneurs Emmet and Toni Stephenson have worked together to build diverse businesses ranging from portfolio management to Internet publishing. When Toni was diagnosed with T cell lymphoma last spring, the couple refocused their energies into restoring her health. Emmet and Toni Stephenson with their daughter Tessa Stephenson Brand “Cancer became the center of our life,” Emmet said. “Our priorities really got changed and turned upside down almost instantly.” “It did change us,” Toni said. “It was quite a summer.” Toni is currently in remission following treatment…

New CMV vaccine targets virus affecting third of transplant patients

February 3, 2014 | by
Vaccine expert John Zaia
In most healthy adults, the immune system wages a winning battle against a virus that infects up to 80 percent of the population by age 40. Most never even know they have cytomegalovirus, or CMV. John Zaia, chair of the Department of Virology, checks on Jasson Duran, the first volunteer enrolled in a study of a new CMV vaccine developed and manufactured at City of Hope. However, the virus is a leading cause of complications and serious illness in patients who have compromised immune systems, including those receiving hematopoietic cell transplants to treat leukemia or lymphoma. CMV…

Pediatric cancer researchers explore new ways to help kids

January 12, 2014 | by
leukemia
Every child fighting cancer is unique — and deserves treatment that recognizes differences in age, developmental stage, background and the cancer he or she is battling. City of Hope conducts groundbreaking research and practices compassionate care that addresses the needs of each child, tailoring treatment to overcome disease. Our commitment to help children fight cancer City of Hope is committed to helping children fight cancer. Our scientists’ groundbreaking research and our physicians’ lifesaving treatments are all part of that commitment. City of Hope is committed to helping children fight cancer, even when prior treatments have…

Exploring cognitive decline after hematopoietic cell transplant

December 17, 2013 | by
Illustration of the human brain
Hematopoietic cell transplant patients who undergo what’s known as myeloablative conditioning (that is, high-intensity chemotherapy and radiation) – and who have shorter telomeres (chromosome “end caps”) – may be at greater risk for cognitive impairment after transplant, City of Hope researchers have found. Their study was presented earlier this month at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans in December. “Our goal was to understand the trajectory of their cognitive functioning after transplantation and also if there are some vulnerable subpopulations at increased risk of cognitive impairment,” said senior author Smita Bhatia, M.D., M.P.H.,…

How to give back: Couple who lost son now help others (w/VIDEO)

December 17, 2013 | by
couple copy
The fourth in a series about how to give, and give back, during the holiday season ... Giving back during the holidays (or year-round) doesn’t have to come in the form of cash, toys or tangible gifts. In fact, it can be done at no cost: One way is by volunteering. Local hospitals, animal shelters and other nonprofit organizations nationwide rely on volunteers to help run daily operations. At City of Hope, volunteers play a special role, bringing compassion, empathy and hope to patients and their families. Gloria and Sal Grill know just how powerful this form…

Why a secondary cancer after transplant? Grant may help find clues

December 11, 2013 | by
DNA analysis
Myelodysplastic syndrome, once known as “preleukemia,” is a disease of the blood and bone marrow that often attacks people who have survived initial cancer treatment. “Good Morning America” co-host Robin Roberts, for example, was diagnosed with the syndrome, known as MDS, in June 2012, five years after successfully undergoing treatment for breast cancer. She’s one of an estimated 12,000 Americans who are diagnosed with the syndrome each year. Smita Bhatia and Ravia Bhatia, researchers at City of Hope, have received a grant from the V Foundation for Cancer Research to study MDS. They’ll be using genomic tools to analyze mutations…

Meet our doctors: Julie Wolfson on cancer in teens, young adults

November 16, 2013 | by
Julie Wolfson
Adolescents and young adults (AYAs) with cancer have different needs and treatment challenges than children or older adults. They’re a unique population because they don’t fit into a distinct group, often falling into a gap between cancer treatment programs designed for children and those designed for adults. City of Hope pediatric oncologist Julie Wolfson Here, pediatric oncologist Julie Wolfson, M.D., M.S.H.S., discusses how the cancer experience differs for AYAs and how City of Hope’s multidisciplinary AYA team offers assistance and a network of professionals to support teens and young adults from the beginning of treatment through…